These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11810567)

  • 1. Evaluation of the activity of antimicrobial agents against Legionella pneumophila multiplying in a human monocytic cell line, THP-1, and an alveolar epithelial cell line, A549.
    Kunishima H; Takemura H; Yamamoto H; Kanemitsu K; Shimada J
    J Infect Chemother; 2000 Dec; 6(4):206-10. PubMed ID: 11810567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila.
    Takemura H; Yamamoto H; Kunishima H; Ikejima H; Hara T; Kanemitsu K; Terakubo S; Shoji Y; Kaku M; Shimada J
    J Antimicrob Chemother; 2000 Oct; 46(4):589-94. PubMed ID: 11020257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.
    Onody C; Matsiota-Bernard P; Nauciel C
    J Antimicrob Chemother; 1997 Jun; 39(6):815-6. PubMed ID: 9222053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of macrolides against intracellular Legionella pneumophila.
    Segreti J; Meyer P; Kapell K
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila.
    Jung R; Danziger LH; Pendland SL
    J Antimicrob Chemother; 2002 May; 49(5):857-61. PubMed ID: 12003984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila].
    Yu LL; Hu BJ; Huang SL; Zhou ZY; Tao LL
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):409-12. PubMed ID: 21781510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan.
    Miyashita N; Kobayashi I; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kurachi S; Ishikawa T; Ishimura Y; Kanesaka I; Kiyota H; Watanabe A
    J Infect Chemother; 2018 May; 24(5):325-329. PubMed ID: 29459000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of azithromycin on intracellular Legionella pneumophila in the Mono Mac 6 cell line at serum concentrations attainable in vivo.
    Jonas D; Engels I; Daschner FD; Frank U
    J Antimicrob Chemother; 2000 Sep; 46(3):385-90. PubMed ID: 10980164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages.
    Walz A; Nichterlein T; Hof H
    Zentralbl Bakteriol; 1997 Feb; 285(3):431-9. PubMed ID: 9084116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
    Pendland SL; Martin SJ; Chen C; Schreckenberger PC; Danziger LH
    J Clin Microbiol; 1997 Nov; 35(11):3004-6. PubMed ID: 9350781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
    Stout JE; Sens K; Mietzner S; Obman A; Yu VL
    Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila.
    Sato T; Tateda K; Kimura S; Ishii Y; Yamaguchi K
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1594-7. PubMed ID: 21220530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of thiamphenicol, erythromycin and fluoroquinolones against Legionella pneumophila.
    Bonfiglio G; Lanzafame A; Santini L; Mattina R
    J Chemother; 2004 Oct; 16(5):502-3. PubMed ID: 15565921
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents.
    Kitsukawa K; Hara J; Saito A
    J Antimicrob Chemother; 1991 Mar; 27(3):343-53. PubMed ID: 2037540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.
    Lemaire S; Van Bambeke F; Tulkens PM
    Int J Antimicrob Agents; 2011 Jul; 38(1):52-9. PubMed ID: 21596526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.